# FDA Inspection 1125020 - Lawrence Gervasi, M.D. - June 30, 2020

Source: https://www.keypedia.com/records/fda_inspections/lawrence-gervasi-md/51a475ff-4690-4527-a80c-9959b63fec34
Source feed: FDA_Inspections

> FDA Inspection 1125020 for Lawrence Gervasi, M.D. on June 30, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1125020
- Company Name: Lawrence Gervasi, M.D.
- Inspection Date: 2020-06-30
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/lawrence-gervasi-md/abd0e933-8fed-408b-8ca5-cf751a60ee60

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c